Observation of pathological interaction of tau with JIP1 and trapping of JIP1 in the soma in AD patients further supports these findings in the mouse model (Ittner et al., 2009), while loss of axonal mitochondria enhances the abnormal phosphorylation and the toxicity of tau. Here, MAPT is linked to Alzheimer disease.